John Neylan
Chief Tech/Sci/R&D Officer presso AKARI THERAPEUTICS, PLC
Patrimonio netto: - $ in data 31/07/2023
Posizioni attive di John Neylan
Società | Posizione | Inizio | Fine |
---|---|---|---|
AKARI THERAPEUTICS, PLC | Chief Tech/Sci/R&D Officer | 08/11/2022 | - |
Storia della carriera di John Neylan
Precedenti posizioni note di John Neylan
Società | Posizione | Inizio | Fine |
---|---|---|---|
ANGN BIOM | Chief Tech/Sci/R&D Officer | 01/12/2018 | 15/08/2022 |
KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 23/04/2015 | 12/12/2018 |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Corporate Officer/Principal | 01/10/2000 | 01/05/2008 |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | Director/Board Member | - | - |
The American Society of Transplantation
The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services The American Society of Transplantation (AST) is a non-profit organization founded in 1982 that aims to advance the field of transplantation and improve patient care through research, education, advocacy, organ donation, and community service. The non-profit company is based in Mount Laurel, NJ. With over 4,000 professional members, AST is the largest transplant organization in the United States and is recognized as the premier society for transplantation. The society is sought out by other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public for guidance, research, and resources related to transplantation. | President | - | - |
University of California, Davis | Corporate Officer/Principal | - | - |
Emory University | Corporate Officer/Principal | - | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2008 | - |
Formazione di John Neylan
Duke University | Undergraduate Degree |
Rush Medical College | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Posizioni
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 5 |
Commercial Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AKARI THERAPEUTICS, PLC | Health Technology |
Aziende private | 6 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | Commercial Services |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Commercial Services |
The American Society of Transplantation
The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services The American Society of Transplantation (AST) is a non-profit organization founded in 1982 that aims to advance the field of transplantation and improve patient care through research, education, advocacy, organ donation, and community service. The non-profit company is based in Mount Laurel, NJ. With over 4,000 professional members, AST is the largest transplant organization in the United States and is recognized as the premier society for transplantation. The society is sought out by other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public for guidance, research, and resources related to transplantation. | Commercial Services |
Angion Biomedica Corp.
Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Borsa valori
- Insiders
- John Neylan
- Esperienza